Composite nano- and micromaterials and methods of making and using same. The composite materials comprise crystalline materials (e.g., binary and ternary vanadium oxides) in an amorphous or crystalline material (e.g., oxide, sulfide, and selenide materials). The materials can be made using sol-gel processes. The composite materials can be present as a film on a substrate. The films can be formed using preformed composite materials or the composite material can be formed in situ in the film forming process. For example, films of the materials can be used in fenestration units, such as insulating glass units deployed within windows.

There is provided a heat insulating film including: a support; a fibrous conductive particles-containing layer; and a protective layer, in this order, in which the fibrous conductive particles-containing layer includes a binder including a material having a maximum peak value of reflectivity for far infrared rays at a wavelength of 5 to 25 m which is equal to or greater than 20% or a material having an average transmittance for far infrared rays at a wavelength of 5 m to 10 m in conversion of a film thickness as 20 m which is equal to or greater than 50%, as a main component, and fibrous conductive particles, and the protective layer includes a material having an average transmittance for far infrared rays at a wavelength of 5 m to 10 m in conversion of a film thickness as 20 m which is equal to or greater than 50%, as a main component. The heat insulating film is manufactured at low cost and satisfies both of a low haze value and high heat insulating properties. A manufacturing method of a heat insulating film; a heat insulating glass; and a window are provided.

The present invention relates to CD3-binding molecules capable of binding to human and non-human CD3, and in particular to such molecules that are cross-reactive with CD3 of a non-human mammal (e.g., a cynomolgus monkey). The invention also pertains to uses of such antibodies and antigen-binding fragments in the treatment of cancer, autoimmune and/or inflammatory diseases and other conditions.

A low-reflection coating of the present invention is a porous film including: fine silica particles being solid and spherical and having an average particle diameter of 80 to 150 nm; and a binder containing silica as a main component, the fine silica particles being bound together by the binder. The binder further contains an aluminum compound. The low-reflection coating contains, as components, 55 to 70 mass % of the fine silica particles, 25 to 40 mass % of the silica of the binder, and 2 to 7 mass % of the aluminum compound in terms of Al.sub.2O.sub.3. The low-reflection coating has a thickness of 80 to 800 nm. The low-reflection coating yields a transmittance gain of 2.5% or more when provided on the substrate. The transmittance gain represents an increase in average transmittance of the substrate provided with the low-reflection coating relative to the substrate not provided with the low-reflection coating, the average transmittance being measured in the wavelength range of 380 to 850 nm.

Described are carbon nanotube dispersions containing single-walled carbon nanotubes dispersed in a dispersant solution comprising a solvent (water, organic polar protic solvents, and/or organic polar aprotic solvents), and an azo compound. The single-walled carbon nanotubes are not cross-linked with covalent bonds. The dispersions are useful for fabricating transparent conductive thin films on flexible and inflexible substrates. Methods for making the transparent conductive thin films are also described.

A panel like, double-sided coated substrate and a method for production are provided. The panel like substrate includes at least two layers applied by heating, the first layer being applied on a first side of the substrate and having at least a glass component and structure-forming particles, the particles producing elevations on the first layer, and the softening temperature or the melting temperature of the particles being greater than the softening temperature of the glass component, and the second layer being applied on a second side of the substrate.

CD3-binding molecules capable of binding to human and non-human CD3, and in particular to such molecules that are cross-reactive with CD3 of a non-human mammal (e.g., a cynomolgus monkey) are presented. Uses of such antibodies and antigen-binding fragments in the treatment of cancer, autoimmune and/or inflammatory diseases and other conditions are presented.

A glass-ceramic article includes at least one substrate, such as a plate, made of glass-ceramic material, the substrate being coated on its lower face, in at least one zone, with at least one fibrous structure including a resin.

A substrate having a coating for enhanced scratch resistance is provided. The coating includes at least one high refractive index transparent hard material layer. The hard material layer includes crystalline aluminum nitride having a hexagonal crystal structure that exhibits a predominant (001) preferred orientation of the hexagonal symmetry.

The present invention relates to CD3-binding molecules capable of binding to human and non-human CD3, and in particular to such molecules that are cross-reactive with CD3 of a non-human mammal (e.g., a cynomolgus monkey). The invention also pertains to uses of such antibodies and antigen-binding fragments in the treatment of cancer, autoimmune and/or inflammatory diseases and other conditions.